Want to see FEAM full AI Analyst Report?
Top Page
5E Advanced Materials, Inc.
(NASDAQ:FEAM)
Select Model
Select Model
Rating:47Neutral
Price Target:
$1.00
▼(-36.31% Downside)
Action:Reiterated
Date:06/10/26
The score is held down primarily by weak financial performance (no revenue, sustained losses, and continued cash burn) and bearish technical signals (trading below major moving averages with negative MACD). Offsetting these risks, the latest earnings call indicates tangible progress toward commercialization and financing (offtake HOA, product development milestones, and a strengthened balance sheet from the $36M raise), but execution and financing remain incomplete.
Positive Factors
Higher-grade meta boric acid & IP
The ~80% B2O3 meta boric acid and provisional patent create product differentiation versus commodity boric acid, supporting premium pricing and entry into higher-margin specialty markets. Over months this strengthens an IP moat, improves revenue per ton potential, and increases strategic optionality for customers and lenders once qualified.
Negative Factors
No revenue and persistent losses
The company reports no revenue and sustained large net losses with negative operating and free cash flow. Without proven sales, the commercial model remains untested, forcing dependence on external capital, raising dilution risk, and constraining the firm’s ability to demonstrate sustainable margins or fund scale-up absent definitive contracts or financing.
Read all positive and negative factors
Positive Factors
Negative Factors
Higher-grade meta boric acid & IP
The ~80% B2O3 meta boric acid and provisional patent create product differentiation versus commodity boric acid, supporting premium pricing and entry into higher-margin specialty markets. Over months this strengthens an IP moat, improves revenue per ton potential, and increases strategic optionality for customers and lenders once qualified.
Read all positive factors
5E Advanced Materials, Inc. (FEAM) vs. SPDR S&P 500 ETF (SPY)
Market Cap
$48.16M
Dividend YieldN/A
Average Volume (3M)250.73K
Price to Earnings (P/E)―
Beta (1Y)1.67
Revenue GrowthN/A
EPS Growth87.35%
CountryUS
Employees35
SectorBasic Materials
Sector Strength58
IndustryChemicals - Specialty
Share Statistics
EPS (TTM)-1.83
Shares Outstanding41,515,224
10 Day Avg. Volume556,167
30 Day Avg. Volume250,726
Financial Highlights & Ratios
PEG Ratio0.01
Price to Book (P/B)0.45
Price to Sales (P/S)0.00
P/FCF Ratio-1.18
Enterprise Value/Market Cap<0.01
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit>-0.01
Enterprise Value/Ebitda>-0.01
Forecast
1Y Price Target
$4.75Price Target Upside202.55% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
EPS Forecast (FY)-1.45
Revenue Forecast (FY)N/A
5E Advanced Materials, Inc. Business Overview & Revenue Model
Company Description
5E Advanced Materials Inc. is actively involved in the discovery and development of mineral assets throughout Australia and the United States. The company's core focus lies in prospecting for valuable deposits of borates and lithium. A significant...
How the Company Makes Money
null...
5E Advanced Materials, Inc. Earnings Call Summary
Earnings Call Date:May 12, 2026
(Q3-2026)
| % Change Since: |
Next Earnings Date:Sep 30, 2026
Earnings Call Sentiment Positive
The call highlighted multiple substantive operational and commercial milestones — a signed offtake heads of agreement (7,500 t/yr, optional to 10,000 t/yr), development and provisional patent filing for a higher-grade meta boric acid (~80% B2O3), initiation of ferroboron trials, a $36M equity raise that was 4x oversubscribed, and active EXIM loan diligence. These accomplishments materially advance commercialization and financing readiness. However, key limitations remain: the offtake is not yet a definitive purchase contract, product qualifications and ferroboron trials are ongoing, and project financing has not been finalized. Overall the progress significantly derisks the project but important execution and financing steps still need to be completed.Positive Updates
First Offtake Heads of Agreement Executed
Signed a long-term offtake heads of agreement for 7,500 tons/year of boric acid with optionality to increase to 10,000 tons/year (+33.3% optional increase). Agreement includes fixed pricing, annual escalation, an initial 5-year term with automatic renewal up to 10 years. Represents a bankable commercial milestone to support lender diligence.
Negative Updates
Offtake Is a Heads of Agreement, Not a Definitive Purchase Contract
The announced offtake is a heads of agreement and a definitive purchase agreement is expected only in conjunction with project finance diligence. Commercial terms are not yet fully executed and revenue projections presented were hypothetical examples.
Read all updates
Q3-2026 Updates
Positive
Negative
First Offtake Heads of Agreement Executed
Signed a long-term offtake heads of agreement for 7,500 tons/year of boric acid with optionality to increase to 10,000 tons/year (+33.3% optional increase). Agreement includes fixed pricing, annual escalation, an initial 5-year term with automatic renewal up to 10 years. Represents a bankable commercial milestone to support lender diligence.
Read all positive updates
Company Guidance
In the Q3 FY2026 call (quarter ended March 31, 2026) management guided that near‑term priorities are converting demand into bankable offtake agreements and advancing financing readiness: they signed a heads‑of‑agreement for 7,500 tons per year of boric acid (option to 10,000 tpa) with an initial 5‑year term and automatic renewal up to 10 years, following a March roadshow meeting 12 end users; they expect additional offtakes to be advanced in the coming weeks/months to support project debt underwriting. Operationally, R&D produced a meta boric acid with ~80% B203 equivalent (versus boric acid at 56.3% B203 and boron oxide ~98% B203), which management illustrated could imply ~$1,750/ton on a 10,000‑ton contract (vs. $1,000/ton for boric acid) — i.e., ~$17.5M vs. $10M annual revenue on 10,000‑ton examples — and noted shipping cost parity; ferroboron crucible testing has commenced with magnet‑grade samples expected in weeks. On financing, the company closed a 4x‑oversubscribed $36M public equity offering in February, reported active EXIM/E&P loan diligence with biweekly calls and an engineering multiplier application for FEED, and plans to begin marketing in Asia in June.5E Advanced Materials, Inc. Financial Statement Overview
Summary
Income Statement
12
Very Negative
Balance Sheet
46
Neutral
Cash Flow
18
Very Negative
| Breakdown | TTM | Jun 2025 | Jun 2024 | Jun 2023 | Jun 2022 | Jun 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit | -10.88M | -20.15M | 0.00 | 0.00 | 0.00 | -5.97M |
| EBITDA | -22.00M | -4.97M | -50.48M | -23.42M | -66.47M | -19.22M |
| Net Income | -43.43M | -31.55M | -62.01M | -30.62M | -66.71M | -19.25M |
Balance Sheet | ||||||
| Total Assets | 78.12M | 70.73M | 89.50M | 100.90M | 70.89M | 64.61M |
| Cash, Cash Equivalents and Short-Term Investments | 25.39M | 3.84M | 4.90M | 20.32M | 31.06M | 40.81M |
| Total Debt | 123.00K | 215.00K | 65.16M | 37.92M | 561.00K | 309.00K |
| Total Liabilities | 5.08M | 7.54M | 78.80M | 47.33M | 8.22M | 2.28M |
| Stockholders Equity | 73.04M | 63.19M | 10.71M | 53.57M | 62.66M | 62.33M |
Cash Flow | ||||||
| Free Cash Flow | -28.07M | -23.76M | -34.06M | -70.78M | -40.02M | -23.07M |
| Operating Cash Flow | -20.02M | -23.64M | -26.87M | -30.70M | -28.61M | -10.89M |
| Investing Cash Flow | -7.89M | -1.97M | -7.19M | -39.31M | -11.40M | -12.96M |
| Financing Cash Flow | 49.27M | 24.55M | 18.63M | 59.27M | 30.62M | 37.77M |
5E Advanced Materials, Inc. Technical Analysis
Negative
1.57
Price Trends
1.61
Negative
1.64
Negative
2.74
Negative
Market Momentum
-0.12
Positive
28.57
Positive
6.97
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For FEAM, the sentiment is Negative. The current price of 1.57 is above the 20-day moving average (MA) of 1.35, below the 50-day MA of 1.61, and below the 200-day MA of 2.74, indicating a bearish trend. The MACD of -0.12 indicates Positive momentum. The RSI at 28.57 is Positive, neither overbought nor oversold. The STOCH value of 6.97 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for FEAM.
5E Advanced Materials, Inc. Risk Analysis
5E Advanced Materials, Inc. disclosed 79 risk factors in its most recent earnings report. 5E Advanced Materials, Inc. reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks
5E Advanced Materials, Inc. Peers Comparison
UnderperformOutperform
Sector (61)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
75 Outperform | $34.64B | 13.38 | 25.07% | 0.51% | -1.28% | 140.98% | |
70 Outperform | $19.66B | 39.96 | 3.40% | 0.74% | 5.01% | -67.33% | |
68 Neutral | $155.16M | 14.44 | 19.91% | ― | 9.32% | 6.78% | |
67 Neutral | $1.09B | 18.43 | 14.22% | 5.46% | 16.65% | -3.36% | |
67 Neutral | $3.13B | 22.97 | 21.28% | 0.19% | 9.49% | 8.32% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
47 Neutral | $48.16M | -0.61 | -70.04% | ― | ― | 87.35% |
* Basic Materials Sector Average
FEAM
5E Advanced Materials, Inc.
1.11
-2.47
-68.99%
CPAC
Cementos Pacasmayo SAA
11.70
6.07
107.82%
CX
Cemex SAB
12.97
5.42
71.72%
MLM
Martin Marietta Materials
562.59
0.57
0.10%
USLM
United States Lime & Minerals
104.97
0.41
0.39%
SMID
Smith-Midland
28.60
-8.67
-23.26%
5E Advanced Materials, Inc. Corporate Events
Business Operations and StrategyDelistings and Listing Changes
5E Advanced Materials to Voluntarily Delist from ASX
Neutral
Apr 17, 2026
On April 16, 2026, 5E Advanced Materials, Inc. announced plans to voluntarily delist its CHESS Depositary Interests from the Australian Securities Exchange, with suspension from official quotation expected on May 26, 2026 and the delisting effecti...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.